Chief Executive Officer

This is a CEO appointment at an early-stage structural heart company developing a differentiated heart valve technology with broader platform potential. The company has completed its seed financing, is backed by investors with both commercial and mission-driven objectives, and is building toward a Series A within 18–24 months. The lead programme is progressing through pre-clinical development toward first-in-human preparation. What the company needs now is a leader to refine a multi-year compan…